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Two noncomplementing vaccinia virus temperature-sensitive mutants, Cts8 and Cts26, were mapped to the A3L gene, which encodes the
major virion structural protein, 4b. The two ts mutants display normal patterns of gene expression, DNA replication, telomere resolution, and
protein processing during infection. Morphogenesis during mutant infections is normal through formation of immature virions with nucleoids
(IVN) but appears to be defective in the transition from IVN to intracellular mature virus (IMV). In mutant infections, aberrant particles that
have the appearance of malformed IMVaccumulate. The mutant particles are wrapped in Golgi-derived membranes and exported from cells.
Purified mutant particles are indistinguishable from wt particles in protein and DNA composition; however, they are defective in a
permeabilized-virion-directed transcription reaction despite containing significant (Cts8) or even normal (Cts26) levels of specific
transcription enzymes. These results indicate that the 4b protein is required for proper metamorphosis of IMV from IVN and that proper
organization of the IMV structure is required to produce a transcriptionally active virion particle.
D 2004 Elsevier Inc. All rights reserved.
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Vaccinia virus, the prototypical member of the poxvirus
family, has a 192-kb double-stranded DNA genome encod-
ing over 200 polypeptides, of which approximately half are
incorporated into virus particles. Poxviruses are unique
among DNA viruses in that the entire life cycle, including
transcription, genome replication, and virus assembly,
occurs in the cytoplasm of host cell and thus the virus
encodes virtually all the enzymes required for these
processes (Moss, 2001).
Mature poxvirus virions exist in four forms designated
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E-mail address: condit@mgm.ufl.edu (R.C. Condit).virus (IEV), cell-associated enveloped virus (CEV), and
extracellular enveloped virus (EEV) (reviewed in Smith et
al., 2002). IMV, the first assembled and simplest infectious
form of virus, is a membraned particle that, as the name
implies, remains inside cells following virus maturation.
IEV is essentially IMV that has acquired two additional
membranes via wrapping in Golgi-derived cisternae. CEV is
derived from IEV by fusion of the outermost IEV membrane
with the plasma membrane and remains attached to the outer
surface of the cell. EEV is a CEV that has been released
from the surface of the cell. EEV and CEV are primarily
responsible for spread of a poxvirus infection in culture and
in infected animals.
The architecture of mature IMV has been analyzed by
electron microscopy of sectioned or negatively stained
preparations of infected cells or purified virus (Dales and
Pogo, 1981; Griffiths et al., 2001a, 2001b). The virion is
unique in structure and has none of the features typical of04) 127–146
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been described as bbrick shapedQ and bcomplexQ. The virion
is usually represented as a biconcave, walled core structure
that is flanked by lateral bodies and surrounded by an outer
membrane. Close inspection of electron micrographs reveals
numerous particles that lack distinct lateral bodies and that
have a rectangular core. These two images probably
represent different projections or sections of the same
structure. High-resolution electron micrographs reveal that
the core wall has two distinct layers, an inner, smooth layer
and an outer, striated or bpalisadeQ layer. The outer
membrane also has a bilaminar structure, but is distinct in
appearance from the core wall.
Several investigators have attempted to determine the
makeup of individual structures within the virion by
analysis of proteins, DNA, and lipid contained in virion
subfractions (see Ichihashi et al., 1984; Jensen et al., 1996).
The virion contains up to 100 proteins (Essani and Dales,
1979), but only a very few specific virus gene products have
been rigorously assigned to any particular structural
compartment in the virion. Treatment of virions with
NP40 and a reducing agent (beta-mercaptoethanol or
DTT) solubilizes the virion outer membrane (Easterbrook,
1966). The virion core with attached lateral bodies can be
recovered by centrifugation (core fraction), leaving a
supernatant fraction (membrane fraction) that contains
virtually all of the lipid in the virus particle plus several
viral proteins. These and other experiments suggest that the
virion outer membrane consists of a proteolipid layer that
rests on or incorporates a basement membrane or matrix,
which in turn consists of several proteins cross-linked with
disulfide bonds. NP40 + DTT-derived core particles contain
most of the major virus structural proteins, virtually all of
the virion enzymes, and the viral DNA. The viral DNA is
thought to reside inside the core wall, complexed with
several viral proteins.
Electron microscopic examination of poxvirus-infected
cells reveals discrete stages of virus morphogenesis with
characteristic intermediate structures associated with each
stage (Dales and Pogo, 1981; Dales and Siminovitch, 1961;
Griffiths et al., 2001a, 2001b; Risco et al., 2002; Sodeik
and Krijnse-Locker, 2002). The earliest evidence of
poxvirus infection is the appearance in the cytoplasm of
discrete granular foci that are largely devoid of normal
cellular organelles. These foci, called bviroplasmQ or bviral
factoriesQ, contain replicating viral DNA. The first evidence
of virion morphogenesis is the appearance within the
viroplasm of rigid, crescent-shaped membrane structures
(cupules in three dimensions) that are precursors to the
IMV membrane. The exact origins and structure of the
crescent membranes have been the subject of some
controversy; they may comprise either one lipid bilayer
or two tightly apposed bilayers (Hollinshead et al., 1999;
Sodeik and Krijnse-Locker, 2002). Crescents evolve into
circles (spheres in three dimensions), called immature
virions (IV), which enclose relatively dense viroplasm.Some IVs contain internal bnucleoidsQ, which are
unbounded, extremely electron-dense DNA containing
structures presumed to be precursors to the virion core.
Formation of these nucleoid-containing IVs, called here
IVN, is associated with viral DNA packaging (Cassetti et
al., 1998; Ericsson et al., 1995; Griffiths et al., 2001a;
Grubisha and Traktman, 2003; Morgan, 1976a). IVN then
matures to IMV containing the classical biconcave core,
core wall, lateral bodies, and outer membrane. Maturation
of IVN to IMV is essentially a metamorphosis that is
presumed to take place via rearrangement of the contents of
IVN (see Discussion). While structures that are thought to
be intermediates in the IVN to IMV transition have been
observed, they are relatively rare and therefore the process
of IMV maturation is probably rapid (Griffiths et al., 2001a;
Risco et al., 2002). Maturation from IVN to IMV is
accompanied by proteolysis of several major virion struc-
tural proteins; mutation of one of the viral proteases
involved in virion protein cleavage interrupts morpho-
genesis at the IVN to IMV transition (Byrd et al., 2002;
Ericsson et al., 1995). Maturation from IVN to IMV is also
accompanied by microtubule-mediated migration of the
particles from viroplasm toward the periphery of the cell
(Sanderson et al., 2000). Greater than 90% of the virus does
not mature past the IMV stage; a small percentage matures
further to eventually be exported from the cell as EEV
(Boulter and Appleyard, 1973).
Analysis of both classical and engineered mutants of
vaccinia has provided insight into the roles of several viral
gene products in virion morphogenesis (see references
Moss, 2001; Smith et al., 2002; Sodeik and Krijnse-Locker,
2002; Traktman et al., 2000). Together, the genes that affect
morphogenesis represent a broad spectrum of functions
including virion structural proteins, protein processing
functions including kinases, proteases, and redox enzymes,
DNA metabolism functions including DNA binding pro-
teins and a Holliday resolvase, RNA metabolism functions
including early transcription initiation factors and an RNA
helicase, and some genes of unknown function. At least
three viral genes have been identified that are required for
the formation of the initial viral membrane crescents within
the viroplasm. As least six additional genes are required for
maturation of precursor crescent membranes into IV. To
date, six genes have been described that are defective in the
formation of IVN from IV and an additional 14 genes are
required for formation of infectious IMV from IVN
particles. Lastly, five genes have been identified that are
required for the synthesis of infectious EEV from IMV.
Many of the mutants studied result in the accumulation of
both precursor particles and apparently aberrant structures,
the study of which may provide further insight into the role
of each gene product in virion morphogenesis.
In the present report, we describe a characterization of
two vaccinia virus temperature-sensitive mutants Cts8 and
Cts26 (Condit and Motyczka, 1981; Condit et al., 1983),
which map to gene A3L (VACWR138), which in turn
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The 4b protein is synthesized as a 72.5-kDa precursor,
named p4b, and proteolytically processed during maturation
of IVN to IMV (Moss and Rosenblum, 1973; Vanslyke et
al., 1991). The C-terminal 60-kDa 4b cleavage product has
been localized to the core wall and accounts for approx-
imately 11% of the virion mass (Ichihashi et al., 1984; Sarov
and Joklik, 1972; Wilton et al., 1995). Our genetic and
biochemical analysis of the A3L mutants reveals a pattern of
viral protein and DNA synthesis, telomere resolution, and
proteolytic processing of major core polypeptides similar to
the wt infection under nonpermissive conditions. Electron
microscopic analysis reveals formation of IV and IVN that
are normal in appearance, an absence of normal IMV, and an
accumulation of aberrant electron-dense virion particles that
in general have the appearance of malformed IMV. Purified
aberrant virions are indistinguishable from wt IMV in
protein composition and contain active RNA polymerase
and early transcription factors. Nevertheless, the purified
aberrant virions are inactive in a permeabilized virion
transcription assay. These results indicate that the A3L gene
product is required for proper metamorphosis of IMV from
IVN and that proper organization of the IMV structure is
required to produce a transcriptionally active virion particle.Fig. 1. One-step marker rescue of Cts8. (From the top down) Positions of four c
genome. The A3L gene, represented as a leftward arrow, is blown up beneath the H
to the blowup. Crystal violet-stained dishes are shown, labeled with the clone usResults
The ts phenotypes of Cts8 and Cts26 are due to mutations
within the A3L gene
Cts8 and Cts26 together comprise a complementation
group of temperature-sensitive mutants that were reported
(data not shown) to possess a bnormalQ phenotype, that is,
they are indistinguishable from wt virus with respect to viral
protein synthesis and DNA replication (Condit and
Motyczka, 1981). Using a library of overlapping cosmid
clones, Thompson and Condit (1986) previously mapped
Cts8 to a region spanning the right hand portion of HindIII
D fragment and the left hand portion of the HindIII A
fragment of vaccinia virus genome. Further preliminary
mapping experiments showed that Cts8 rescued with a wt
DNA subfragment from the left end of the HindIII A
fragment containing genes A1L through a portion of A4L
(data not shown). Based on the preliminary phenotype of
Cts8 and its complementation with other mapped mutants
within this region, the A3L gene was a strong candidate for
the location of Cts8. We therefore investigated whether the
A3L open reading frame was capable of rescuing Cts8 and
Cts26 to the wt phenotype by marker rescue.osmid clones of vaccinia DNA relative to a HindIII restriction map of the
indIII restriction map and the position of the clone pGA3L is shown relative
ed in the transfection.
Table 1
Genomic DNA-enhanced, two-step marker rescue of Cts26
Transfected DNA Virus titer
(pfu/ml) 31 8C
Virus titer
(pfu/ml) 40 8C
– 1.5  102 –
pGA3L 1.2  105 3.5  103
Cts26 1.4  102 –
pGA3L + Cts26 4.9  105 3.8  104
pWR 93–130 7.0  106 1.5  106
pWR 93–130 + Cts26 2.4  106 4.9  105
Fig. 2. One-step growth of wt, Cts8, and Cts26 viruses. Cells were infected
at moi = 10 pfu/cell with wt or mutant viruses, incubated at 31 or 40 8C for
the indicated periods of time (abscissa), and virus yields were determined
by plaque titration at 31 8C (ordinate).
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protocol. Briefly, confluent monolayers of BSC40 cells
were infected with the Cts8 virus and transfected with
overlapping cosmids derived from the vaccinia virus
genome that spans the entire HindIII A fragment (Thompson
and Condit, 1986) or pGA3L plasmid. Cells were incubated
at 40 8C for 4 days and stained with crystal violet. Rescue of
the ts lesion to wt is indicated by the appearance of plaques
on the infected, transfected dishes. Fig. 1 shows that Cts8
was rescued by the cosmid pWR93–130 and pGA3L vector,
demonstrating that Cts8 maps to gene A3L.
Three separate attempts to map the Cts26 mutant using a
one-step marker rescue protocol were unsuccessful; there-
fore, a genomic DNA-enhanced, two-step marker rescue
was performed (Fathi et al., 1986). Table 1 shows that both
pWR93–130 and pGA3L successfully rescued Cts26,
evidenced primarily by the appearance of wt virus, that is,
virus that plaques at 40 8C. Rescue with pGA3L was
enhanced 10-fold by addition of genomic Cts26 DNA as
previously described (Fathi et al., 1986). These results
confirm that both Cts26 and Cts8 map to the A3L gene, as
predicted by complementation analysis. Gene A3L encodes
the p4b protein, precursor of one of the major core
polypeptides 4b (Rosel and Moss, 1985).
To determine the precise mutations that cause temperature
sensitivity in Cts8 and Cts26, the complete nucleotide
sequence of the A3L gene was determined for each mutant.
Cts8 contains a T to C transition in the second position of
codon 562, substituting a valine for an alanine (A562V).
Cts26 contains two mutations, a C to T transition in the
second position of codon 192, substituting a phenylalanine
for a serine (S192F), and a C to T transition in the second
position of codon 341, also substituting a phenylalanine for a
serine (S341F). Because reversion of Cts26 to wt is
undetectable and because Cts26 was difficult to rescue, we
speculate that either one of the individual Cts26 mutations
alone is sufficient to confer a ts phenotype to the Cts26 virus.
Growth characteristics of Cts8 and Cts26 mutant viruses;
virion thermolability
The growth properties of Cts8 and Cts26 were determined
in a one-step growth experiment. Cells were infected at high
moi with either wild-type virus or the ts mutants, incubated at
both permissive and nonpermissive temperatures, harvestedat various times postinfection, and assayed for virus yield by
plaque titration at 31 8C (Fig. 2). Wild-type viruses grown at
31 or 40 8C produced 25–50 pfu per cell by 72 h
postinfection. The growth of Cts8 virus at the permissive
temperature was virtually indistinguishable from wild type,
whereas at 40 8C no growth above background was observed.
The Cts26 mutant grew poorly at 31 8C and the growth
plateaued at 11 pfu/cell, whereas at 40 8C no infectious
progeny was detected. Cts26 also forms relatively small
plaques at the permissive temperature (data not shown),
consistent with its slow growth in a one-step growth
experiment.
Because the A3L gene encodes the major virion protein
4b, Cts8 and Cts26 viruses grown at 31 8C contain mutant
protein. Virion thermolability assays were therefore done as
previously described (Fathi and Condit, 1991) to test whether
the mutant virions themselves are thermolabile. Briefly, Cts8,
Cts26, and wt virus suspensions were incubated for various
times postinfection at 45 8C and virus titers were determined
by plaque assays at 31 8C. Fig. 3 shows that the wt virion
Fig. 3. A3L mutant virions are not thermolabile. Virus lysates containing
approximately 104 pfu/ml were incubated at 45 8C for varying periods of
time (abscissa) and the amount of infectious virus remaining (ordinate)
determined by plaque formation at 31 8C.
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a 4-h period. The decay in infectivity of Cts8 and Cts26
virions was indistinguishable fromwt virions, thus themutant
virions are not thermolabile.Fig. 4. Protein synthesis in wt and mutant-infected cells. Cells were infected at
methionine at various times postinfection, indicated in h at the bottom of each autor
and autoradiographed. Incubation temperature is indicated at the top of each colum
left of each row of autoradiograms. Approximate molecular weights, in kDa, are
indicated to the left of each autoradiogram: L,S = late viral protein; C, x = cEffect of ts mutations on viral protein synthesis
The complementation group comprising Cts8 and Cts26
was previously reported (data not shown) to have a bnormalQ
phenotype, specifically an orderly progression through
early, intermediate, and late gene expression that was
unimpaired relative to a wt infection at the nonpermissive
temperature (Condit and Motyczka, 1981). To confirm and
extend the normal phenotype, the pattern of viral protein
synthesis was determined in infected cells. Cells were
infected with either wt, Cts8, or Cts26, incubated at 31 or 40
8C, proteins were pulse-labeled at various times post-
infection with 35S-methionine, separated by SDS-PAGE,
and detected by autoradiography (Fig. 4). The normal
pattern of viral protein synthesis is represented by wt
infection at 31 or 40 8C. Shutoff of host cell protein
synthesis and the appearance of viral early proteins are
evident at 2–4 h postinfection. Late viral protein synthesis
begins at 4–6 h postinfection and persists throughout the
experiment. Relative to the wt infection, an identical patternmoi = 10 pfu/cell, incubated at 31 or 40 8C, and pulse-labeled with 35S
adiogram. Lysates were electrophoresed on SDS-PAGE, and gels were dried
n of autoradiograms, and the mutant used in the infection is indicated to the
indicated to the right of each autoradiogram. Examples of protein class are
ellular protein; E, o = early viral protein.
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at 31 or 40 8C. It is noteworthy that normal synthesis of the
A3L gene product p4b (the prominent late polypeptide
running at 72 kDa) was observed. Cts26 infections
displayed a delayed pattern of protein synthesis at both 31
and 40 8C; shutoff of host cell protein synthesis was slow,
and the onset of late viral protein synthesis was delayed by
approximately 4 h (Fig. 4). Cts26 also displayed a very
slight effect of temperature on viral protein synthesis.
Whereas in both wt and Cts8 infections, late viral protein
synthesis begins approximately 2 h earlier at 40 8C relative
to 31 8C, in Cts26 infections, late viral protein synthesis
begins at approximately the same time at both temperatures.
In summary, both Cts8 and Cts26 possess bnormalQ
phenotypes as originally defined (Condit and Motyczka,
1981), although Cts26 behaves as a generally bsickQ virus
even at the permissive temperature as evidenced by small
plaque formation, poor growth in a one-step analysis, and
delayed late viral protein synthesis. It is possible that Cts26
contains an additional mutation outside the A3L gene that
compromises its growth at both the permissive and non-
permissive temperatures.
Proteolytic processing of viral proteins
Proteolytic processing of several virion proteins is
associated with maturation from IVN to IMV during
morphogenesis (Garcia and Moss, 2001; Klemperer et al.,Fig. 5. Proteolytic processing of viral proteins in wt and Cts8-infected cells. Cells w
with 35S methionine at 8 h postinfection, indicated as b0Q at the bottom of each a
various times following the pulse, indicated in h at the bottom of each autoradiog
autoradiographed. Incubation temperature is indicated at the top of each column of
of each row of autoradiograms. Approximate molecular weights, in kDa, are indi1997; Ravanello and Hruby, 1994; Zhang and Moss,
1991), and mutation of a virus-coded protease implicated
in cleavage of virion proteins arrests virion morpho-
genesis at the IVN stage (Byrd et al., 2002; Ericsson et
al., 1995; Kane and Shuman, 1993). Therefore, process-
ing of virion polypeptides is a good marker for staging
defects in virus assembly. To test whether the major
virion core polypeptides were processed normally during
infection with Cts8 and Cts26, we carried out pulse-chase
labeling experiments. Cells were infected with wt or
mutant viruses, incubated at 31 or 40 8C, and pulse-
labeled with 35S-methionine at 8 h postinfection. Cells
were either harvested immediately after labeling or at
various times after initiation of a chase in the presence of
unlabeled amino acids, and analyzed by SDS-PAGE and
autoradiography (Fig. 5). Normal proteolytic processing is
evidenced by the decrease in intensity of two prominent
bands of 102 and 72 kDa, representing the precursor
proteins p4a and p4b, respectively, and the accumulation
of bands at 62 and 60 kDa that represent the processed
forms of these proteins 4a and 4b. The results showed
that Cts8 processes virion precursors at both permissive
and nonpermissive temperatures in a fashion that is
indistinguishable from a wt infection. Cts26 infections
also processed virion polypeptides normally (data not
shown). These results suggest that the block to develop-
ment of virus in these A3L mutant infections may occur
at a stage subsequent to formation of IVN.ere infected at moi = 10 pfu/cell, incubated at 31 or 40 8C, and pulse labeled
utoradiogram. Labeled samples were chased with unlabeled methionine for
ram. Lysates were electrophoresed on SDS-PAGE, and gels were dried and
autoradiograms, and the mutant used in the infection is indicated to the left
cated to the right of each autoradiogram.
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The vaccinia genome is replicated as concatemers that are
resolved into mature monomeric forms and encapsidated
during virion morphogenesis (Moyer and Graves, 1981).
Resolution of concatemers requires late viral gene expression
and specific cis elements (DeLange andMcFadden, 1987; Du
and Traktman, 1996; Merchlinsky and Moss, 1989). Reso-
lution of concatemers is probably normally an early event in
virus morphogenesis since mutants that are defective in the
very earliest stages of viral membrane synthesis are com-
petent to resolve concatemers (Traktman et al., 1995).Fig. 6. Telomere resolution in wt and mutant-infected cells. (Top) A diagram sho
DNA hairpin ends. Shaded areas represent direct repeats within the viral termini.
mutant virus at moi = 10 pfu/cell and incubated at 31 or 40 8C as indicated. DNAw
autoradiogram, cleaved with BstEII, Southern blotted, and probed with a 32P-lab
bands, indicated to the right of each autoradiogram, represent unresolved and re
internal fragments hybridized to the probe due to the presence of tandem repeatConcatemer resolution is required for complete morpho-
genesis since mutation of the virus Holliday junction
resolvase (gene A22R) blocks both telomere resolution and
normal maturation beyond the formation of IVN (Garcia and
Moss, 2001). Cts8 was initially characterized as normal for
DNA synthesis, but concatemer resolution has not been
analyzed (Condit and Motyczka, 1981). Resolution of viral
concatemers during Cts8 and Cts26 infection was therefore
determined using the Southern blotting technique described
by Merchlinsky and Moss (1989). DNA isolated from cells
infected with wt or mutant viruses at 31 or 40 8Cwas digested
with BstEII, hybridized in a Southern blot with a vacciniawing relevant features of the viral genome concatemer junction and mature
(Bottom) Autoradiograms of Southern blots. Cells were infected with wt or
as extracted at various times postinfection, indicated in h at the top of each
eled DNA containing concatemer junction sequences. The 2.6- and 1.3-kb
solved end fragments, respectively. The slower migrating bands represent
sequences.
S.E.M. Kato et al. / Virology 330 (2004) 127–146134virus DNA probe containing genomic terminal DNA
sequences. Upon digestion with BstEII, mature monomeric
genomes yield a 1.3-kb terminal fragment, whereas DNA
concatemers yield a 2.6-kb concatemer junction fragment
(Fig. 6). The mutant Cts53, an RNA polymerase mutant
defective in late protein synthesis and telomere resolutionFig. 7. Electron micrographs of wt and mutant-infected cells. Cells were infected wi
and processed for electronmicroscopy as described inMaterials andmethods. (A and
particle; bIVNQ = immature virus particle with nucleoid. (C and D) wt infections at
wt infections at high temperature. (E and F) Cts8 infections at 40 8C. bAQ = aberran
the migration of aberrant particles from viroplasm. The inset in F shows a high
internal structure and the bilaminar appearance of the outer membrane. (G and H
particles: lower left = intracellular enveloped aberrant particle wrapped in two add
in one additional membrane.(Hooda-Dhingra et al., 1989; Merchlinsky and Moss, 1989),
served as control for defective concatemer resolution,
showing accumulation of the 2.6-kb concatemer junction
fragment at 40 8C. In a wt infection, viral concatemer
junctions were completely resolved either at 31 or 40 8C,
indicated by the presence of a 1.3-kb fragment and theth wt or mutant virus at a moi = 10 pfu/cell, incubated at 31 or 40 8C for 24 h,
B) wt infections at 31 8C. bCQ = crescent membrane; bIVQ = immature virus
40 8C. The arrowhead in C represents a half-filled particle sometimes seen in
t particles; bVQ = viroplasm. The lower magnification view in E emphasizes
magnification picture of an aberrant particle, emphasizing the disorganized
) Cts26 infections at 40 8C. The insets in H show extra enveloped aberrant
itional membranes; middle right = extracellular enveloped particle wrapped
Fig. 7 (continued).
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indistinguishable from the wt infection, thus Cts8 resolves
concatemer junctions normally. The Cts26 infection revealed
a very slight accumulation of the unresolved concatemers at
the earlier time points at 40 8C, but by 24 h postinfection
showed complete concatemer resolution.
Cts8 and Cts26 accumulate aberrant particles
Transmission electron microscopy was used to further
investigate the stage at which Cts8 and Cts26 virusreplication was blocked under nonpermissive conditions.
Briefly, BSC40 cells were infected with Cts8, Cts26, or wt
viruses and incubated at 31 or 40 8C for 24 h and then fixed
and processed for electron microscopy. In cells infected with
wt virus incubated either at 31 or 40 8C, all stages of vaccinia
virus morphogenesis were observed (Figs. 7A–D), including
viral crescent membranes, immature virions (IV), immature
virions with nucleoids (IVN), and intracellular mature
virions (IMV). Importantly, at 40 8C, some abnormal
structures were observed, probably as a consequence of
stress imposed by high-temperature incubation. Note in
Fig. 8. Sucrose density gradient sedimentation of wt and mutant particles. Cells were infected at moi = 10 pfu/cell with wt or Cts8, incubated at 40 8C for 24 h,
and cytoplasmic extracts were purified as described in Materials and methods. Fractions of the sucrose density gradients were analyzed by SDS-PAGE and
silver staining (bproteinQ), or slot blotting and hybridization with a vaccinia DNA specific probe (bDNAQ). Fraction numbers are indicated between the gels and
the slot blots; the top and bottom of each gradient are indicated. Approximate molecular weights, in kDa, are indicated at the right of the gels.
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filled with a dense viroplasm (arrowhead in Fig. 7C) and a
relative abundance of IMV bearing apparently bhollowQ
cores (Fig. 7D). Cells infected with Cts8 and Cts26 at 31 8C
were indistinguishable from wt infections done at 31 8C (data
not shown). Cells infected with Cts8 or Cts26 at 40 8C were
indistinguishable from each other, but very distinctly differ-
ent from that of wt infections under nonpermissive con-
ditions (Figs. 7E–H). Morphogenesis in mutant infections
appeared normal through formation of IVN: infected cells
showed a normal abundance of viroplasm, crescents, IV, and
IVN. However, in these mutant infections, normal IMVs
were completely lacking. Instead, mutant-infected cells
contained an abundance of uniquely aberrant particles. The
aberrant particles were either spherical or irregular in shape,Table 2
Characteristics of purified A3L mutant particles
Virusa Yield (particles/cell)b Infectivity (particles/pfu)
wt37 2128 64
wt40 580 42
Cts8 783 4750
Cts26 419 1260
a wt37 = wild-type virus grown at 37 8C from a low moi infection; wt40 =
wild-type virus grown at 40 8C from a high moi infection. See Materials
and methods.
b Calculated from an A260 reading of purified virus, assuming a 1 A260 =
1.2  1010 particles/ml.and they were surrounded by a distinctly double-layered
membrane (Fig. 7F, inset). The aberrant particles were filled
with material of two distinct densities, both more dense than
the viroplasm contained in normal IV. The highest density
material contained in the aberrant particles was not uniform
in shape or location within the particle. The aberrant particles
were not localized to virosomes but rather found in groups at
the periphery of the virosomes or more remote locations in
the cell cytoplasm typical of normal IMV. In summary, these
findings indicate that the A3L gene product is not required
for formation of normal IVN, but plays an essential role
during the transition from IVN to IMV.
Interestingly, electron microscopy strongly suggested that
the aberrant particles were exported from cells in a normal
fashion. Specifically, in both Cts8 and Cts26 infections done
at nonpermissive temperature, particles with two additional
membranes were observed in the cytoplasm (Fig. 7H, inset
lower left), and particles with one additional membrane were
observed outside the infected cells (Fig. 7H, inset middle
right). We suggest that the doubly wrapped particles are the
equivalent of normal intracellular enveloped virions (IEV),
while the extracellular singly wrapped particles are the
equivalent of normal extracellular enveloped virions (EEV).
Importantly, these wrapped particles provide a direct com-
parison between aberrant particle membrane and the wrap-
ping membrane, emphasizing that the structure surrounding
the aberrant particle is a double membrane whereas the
Fig. 9. Analysis of protein and DNA composition of purified wt and mutant particles. (A) SDS-PAGE and Coomassie blue staining of purified particles. bMQ =
markers; molecular weights are indicated to the right of the gel, in kDa. The left three sample lanes contain 5 Ag of each virus; the right three sample lanes
contain 15 Ag of each virus. (B) Western blot analysis of purified particles. Blots were prepared and probed as described in Materials and methods. The gene
product and function corresponding to each antiserum used are indicated to the left of each row; the virus sample probed is indicated at the top of each column.
ND = not done. (C) Core and membrane fractions of purified particles were prepared as described in Materials and methods, and analyzed by SDS-PAGE and
silver staining. bPQ = pellet (core) fraction; bSQ = supernatant (membrane) fraction. Approximate molecular weights, in kDa, are indicated to the right of the gel.
(D) Pulsed-field gel electrophoresis of virion DNA. Purified particles were disrupted and electrophoresed as described in Materials and methods. An ethidium
bromide-stained gel is shown. bMQ = markers; sizes are indicated in kb at the right of the gel. (For interpretation of the references to colour in this figure legend,
the reader is referred to the web version of this article.)
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inset middle right). Note also that the doubly wrapped
cytoplasmic particle is surrounded by fibers, possiblyFig. 10. Electron microscopic analysis of purified wt and Cts8 particles.
Purified particles grown at 40 8C were embedded, stained, and sectioned for
electron microscopy as described in Materials and methods. (A) wt
particles; inset shows a bclassicalQ projection of a wt IMV from elsewhere
in the same section. (B) Cts8 particles.representing connection with the microtubular system on
which normal intracellular IEVs are transported. In summary,
these results suggest that the aberrant particles in Cts8 and
Cts26 infections are wrapped in Golgi-derived membranes
and exocytosed as if they were normal IMV.
Protein and DNA composition of purified aberrant virus
particles
In order to further investigate the structure of the aberrant
particles accumulated during Cts8 and Cts26 infections
under nonpermissive conditions, viral particles were purified
from cells infected under nonpermissive conditions. A light
scattering band was visible at similar position in each tube
following sucrose density gradient centrifugation of infected
cell extracts (not shown). Aliquots of the sucrose gradient
fractions were analyzed both for protein by SDS gel
electrophoresis and silver staining, and for viral DNA by
slot blot hybridization with radiolabeled vaccinia DNA
Fig. 11. Transcription directed by purified wt and mutant particles. Particles grown at 40 8C and purified were permeabilized with NP40, incubated with 32P
rNTPs, and acid precipitable radioactivity was determined at various times of incubation as described in Materials and methods. (A) Total transcription;
reactions incubated at 31 8C. (B–D) Transcription reactions were incubated at 37 8C and at various times (abscissa) separated into core associated (bcoreQ) and
released (bsupQ) by centrifugation as described in Materials and methods. (E) Total virion synthesized RNA was purified and analyzed by electrophoresis on
denaturing formaldehyde agarose gels; gels were dried and autoradiographed. Virus sample and time of incubation are indicated at the top of each
autoradiogram; RNA size markers are indicated to the left of the autoradiogram, in kb. The autoradiogram on the left was exposed for 2 days; the Cts8
autoradiogram on the right was a 5-day exposure of the Cts8 gel on the left.
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of wt and Cts8 particles reveals virtually identical patterns of
viral proteins cosedimenting with the light scattering band.
The slot blot hybridization shows similar quantities of viral
DNA cosedimenting with the particles. Sucrose gradient
fractions containing virus particles were pooled, concen-
trated by centrifugation, and subjected to further analysis.Mutant virus infections produced a normal number of
particles per cell relative to the most appropriate control,
namely a wt infection at 40 8C (Table 2). However, as
expected, the infectivity of the mutant particles was greatly
reduced, 30- to 100-fold, relative to wt particles (Table 2).
Direct comparison of purified particles by SDS gel electro-
phoresis and staining with Coomassie blue reveals no major
Fig. 12. Specific transcription directed by soluble extracts of purified wt
and mutant particles. Soluble transcription extracts from purified particles
were incubated with 32P rNTPs and early or late vaccinia promoter-
containing DNA templates. RNA products were analyzed by electro-
phoresis on denaturing polyacrylamide gels and autoradiography. (A) An
autoradiogram of transcription products. The particle source of extract is
indicated at the top. bEQ = early promoter template; bLQ = late promoter
template. (B) The gel in A was quantified with a phosphorimager, and the
early promoter activity graphed, setting the signal produced by the wt40
extract at 100%.
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particles (Fig. 9A). Of note, the prominent band at 62–65 kDa
is a doublet in each case, corresponding to the major virion
proteins 4a and 4b. Analysis by Western blot for several
specific viral proteins, including both core and membrane
structural proteins and several virion enzymes, also revealed
no differences between wt and mutant virions (Fig. 9B). The
Western blot analysis confirms that themutant virions contain
normal amounts of the mutant 4b protein. Wt and mutant
particles were separated into membrane and core fractions by
treatment with NP40 and DTT followed by centrifugation
and electrophoretic analysis of the soluble membrane fraction
and the pelleted core fraction (Fig. 9C). Again, no differences
were observed in the protein profile of either the core or
membrane fractions when wt and mutant virions were
compared. Lastly, the integrity of the viral DNA in mutant
virions was assayed by pulse field gel electrophoresis of wt
and mutant virion DNA (Fig. 9D). Wt and mutant virions
contained similar amounts of genomic virion DNA, approx-
imately 200 kb in size in all cases, and no evidence of
degradation was observed. In summary, analysis of purified
mutant particles shows that they are indistinguishable from
wt particles with respect to both protein and DNA content.
The morphology of purified particles was investigated by
electron microscopy (Fig. 10). Purified wt particles showed
an abundance of typical IMV structures (Fig. 10A). By
contrast, preparations of purified Cts8 particles contained no
normal IMV (Fig. 10B). Instead, Cts8 particles were eitherspherical or irregular in shape, were bounded by an apparent
double membrane structure, and contained material of two
different densities. The higher density internal structure is
reminiscent of a normal core and is bounded by a wall-like
structure. However, relative to the classical wt IMV, the
Cts8 bcoreQ is misshapen, often off center relative to the
outer boundary of the particle. In general, the appearance of
the purified mutant particles is consistent with the appear-
ance of the aberrant structures observed in infected cells. In
summary, the biochemical and microscopic analysis of A3L
mutant virions shows that while they are apparently normal
in protein and DNA content, they have an abnormal internal
and external morphology relative to wt IMV.
Mutant particles are defective in mRNA synthesis
Mature poxvirus virions contain all of the enzymes
required for specific synthesis, capping, polyadenylation,
and export from virions of early virus mRNA. The virion
transcription apparatus can be assayed by permeabilizing
virions with a neutral detergent and incubating with nucleo-
side triphosphates; export from virions can be assayed by
centrifugation of transcription reactions to separate core-
associated (pelleted) from extruded (supernatant) RNA. To
assess the function of the aberrant particles, purified mutant
particles grown at 40 8C were permeabilized and assayed for
transcription (Fig. 11). Cts8 virions showed less than 2% of
the wt levels of transcription, while Cts26 virions showed
approximately 12% if the wt levels of transcription (Figs.
11A–D; note the different scales comparing B–D). The same
differences were observed whether the transcription reactions
were incubated at 31 8C (Fig. 11A) or 37 8C (Figs. 11B–D).
The small amount of RNA transcribed from mutant virions
was efficiently exported from virions into the supernatant of a
pelleted transcription reaction (Figs. 11B–D). Electrophoretic
analysis shows that Cts26 RNA synthesized from virions was
of a normal size distribution relative to wt RNA while the
Cts8 RNA synthesized from virions appeared slightly larger
than wt RNA (Fig. 11E). We have not investigated further the
apparent size increase in the Cts8-synthesized RNA. In
summary, the Cts8 and Cts26 virions were defective in
overall levels of virion-directed transcription, while the
residual transcription observed was mostly wt in character.
Despite the apparently normal protein and DNA content of
purified mutant virions, it seemed nevertheless possible that
the defects observed in transcription by permeabilized mutant
virions resulted from a lack of some essential virion enzyme
in mutant virions. To further test this possibility, soluble
extracts were made from wt and mutant virions, and assayed
for both nonspecific RNA polymerase activity and for
vaccinia promoter-specific transcription. Wt and mutant
virions contained equivalent amounts of nonspecific RNA
polymerase activity (not shown). Specific transcription was
assayed by incubating extracts in the presence of DNA
templates that contained G-less cassettes driven by either
early or late vaccinia promoters in the presence of radio-
S.E.M. Kato et al. / Virology 330 (2004) 127–146140labeled rNTPs and 3V-O-methyl GTP. The expected 400-bp
transcription product was detected by denaturing polyacry-
lamide gel electrophoresis and autoradiography (Fig. 12).
The results show that both wt and mutant extracts contained
early viral promoter-specific transcription activity, but were
inactive on late vaccinia promoters (Fig. 12A). Quantita-
tively, the virions purified after optimal conditions of
infection, low moi at 37 8C, were the most active in specific
transcription (Fig. 12B, wt37). Relative to the most appro-
priate control, that is, wt virus purified from cells infected at
high moi and incubated at 40 8C (Fig. 12B, wt40), Cts8
extracts contained 30% of wt40 activity and Cts26 contained
over 100% of wt40 activity. Thus, the severe defect in
transcription observed in permeabilized virions cannot be
accounted for by a deficiency in active core viral RNA
polymerase or early transcription factors in virions.Discussion
We describe here two temperature-sensitive mutants,
Cts8 and Cts26, which affect the vaccinia virus A3L gene.
The A3L gene encodes the major virion structural protein
4b, which is synthesized as a precursor, p4b, and proteolyti-
cally processed during virus morphogenesis. The two ts
mutants show only minor differences in phenotype. They
display normal patterns of gene expression although Cts26
shows a somewhat slowed progression through the early
and late phases of protein synthesis, consistent with its
relatively poor growth at permissive temperature. Both
mutants are normal for DNA replication, telomere resolu-
tion, and protein processing during infection. Morpho-
genesis during mutant infections is normal through
formation of immature virions with nucleoids (IVN) but
appears to be defective in transition from IVN to intra-
cellular mature virus (IMV). The mutant particles formed
are either spherical or irregular in shape and possess two
distinct internal densities, the more dense of which is
bounded by a wall and is suggestive of an aberrant core. The
mutant particles are wrapped in Golgi-derived membranes
and exported from cells, suggesting that they possess a
normal complement of functional surface components
required for interaction with the wrapping and exocytosis
machinery. Incidentally, the aberrant particle membrane is
clearly a two-layer structure as contrasted directly with the
Golgi-derived membranes in wrapped aberrant particles,
supporting the two bilayer model for IMV membrane
biogenesis. Purified mutant particles are indistinguishable
from wt particles in protein and DNA composition;
however, they are defective in a permeabilized-virion-
directed transcription reaction despite containing significant
(Cts8) or even normal (Cts26) levels of specific tran-
scription enzymes.
Previous analysis supports a sequencing of events in the
later stages of vaccinia morphogenesis in which IV is a
precursor of IVN and IVN is a precursor of IMV. Insynchronized high-multiplicity infections, IV and IVN
appear in the cytoplasm prior to the appearance of IMV
(Dales and Siminovitch, 1961), and several mutants have
been characterized that form IV but not IVN or IMV
(Cassetti et al., 1998; Grubisha and Traktman, 2003), or IV
and IVN but not IMV (Klemperer et al., 1997). IVNs are
thought to be IVs that have undergone packaging of viral
DNA. Several independent electron microscopic studies
provide images of what appear to be IV in the act of
packaging a dense nucleoid structure, and the nucleoid of
IVN labels with anti-DNA antibodies using immunoelectron
microscopy (Ericsson et al., 1995; Griffiths et al., 2001a;
Morgan, 1976a, 1976b). Two different mutants have been
described that are specifically defective in packaging of
DNA (Cassetti et al., 1998; Grubisha and Traktman, 2003).
Importantly, in both of these mutant infections, IVs are
formed normally, but IVNs (and IMV) are either absent or
significantly decreased in number, and spherical particles
that lack DNA accumulate in the viroplasm.
The transition from IVN to IMV during vaccinia
morphogenesis is poorly understood. The immature particle
(IV and IVN) membranes are equivalent to the IMV
membrane because both types of particles label with
antibodies specific for several viral membrane proteins as
assessed by immunoelectron microscopy (see Griffiths et
al., 2001a; Rodriguez et al., 1997; Traktman et al., 2000).
The transition to IMV thus involves significant internal
restructuring of the immature particles including, impor-
tantly, formation of a discrete core, core wall, and lateral
bodies. In wild-type virus infections, structures have been
observed that have been interpreted as representing mor-
phogenetic intermediates between IVN and IMV (Dales and
Siminovitch, 1961; Griffiths et al., 2001a; Moss, 2001;
Risco et al., 2002); however, these structures are rare,
suggesting that the transition between IVN and IMV is
either a very rapid or perhaps highly concerted transition.
In addition to obvious morphological changes, two
events mark the transition from IVN to IMV: cleavage of
virion protein precursors and microtubule-dependent move-
ment of the particles from viroplasm to more remote
locations within the cytoplasm. The proteolytic processing
observed during vaccinia virion morphogenesis seems to be
coordinated with and in fact may be required for the
transition from IVN to IMV. In mutants where IMV
formation is blocked and IVs accumulate, proteolytic
processing is not observed (see Grubisha and Traktman,
2003; Ravanello and Hruby, 1994; Senkevich et al., 2002).
Conversely, in several mutants where normal-looking but
noninfectious IMVs accumulate, proteolytic processing
occurs normally (see Fathi and Condit, 1991; Senkevich et
al., 2004; Wilcock and Smith, 1994). Perhaps most
important, mutation of the I7L protease that is responsible
for cleavage of at least some of the virion structural protein
precursors, results in virion morphogenesis that is normal
through the IVN stage but defective in later stages. In
infections done with ts mutants in the I7L protease, no
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1993), while in infections done with inducible mutants in
which the I7L protein is repressed, aberrant particles
accumulate that bear striking similarity to the aberrant
A3L mutant particles described here (Ansarah-Sobrinho and
Moss, 2004). Microtubule-dependent movement of particles
out of the viroplasm requires the A27L gene, which encodes
a 14-kDa fusion protein localized to the IMV membrane
(Sanderson et al., 2000). The A27 protein seems to be added
to the maturing particle membrane very late during morpho-
genesis, because immunoelectron microscopy reveals that
IVs lack the A27 protein while IMV and a presumed IV–
IMV intermediate label with anti-A27 antibody (Sodeik et
al., 1995). In cells infected with A27L null mutants, IMVs
are formed, but their transport on microtubules is inhibited,
and they accumulate abnormally in the viroplasm along with
immature forms of the virus (Sanderson et al., 2000). Thus
these two events, proteolysis and export from viroplasm,
can be used to distinguish between IVN-like or IMV-like
particles in mutant infections where abnormal particles
accumulate. In these respects, the aberrant particles
observed during the A3L mutant infections described here
are IMV-like since proteolysis of virion structural protein
precursors occurs normally and the aberrant particles are
exported from the viroplasm.
The precise protein composition of immature particles is
difficult to assess because normal IV and IVN are difficult
to isolate in sufficient quantity or purity to permit rigorous
biochemical study. Several mutants have been identified in
which IVs or IVNs accumulate in the absence of IMV or
aberrant particles; however, most attempts to purify
immature virions from these mutant infections have failed,
suggesting that normal IV and IVN are relatively unstable
(Hu et al., 1996; Klemperer et al., 1997; Ravanello and
Hruby, 1994). Several mutants have been described in
which processing of virion structural protein precursors is
inhibited, and abnormal particles accumulate in viroplasm;
because proteolysis is absent in these mutants and because
the particles accumulate specifically in the viroplasm, the
particles may be thought of as IV- or IVN-like. In some
cases, these particles are sufficiently stable for purification
and biochemical study, and in all such cases, the protein
composition of these aberrant immature particles is
virtually identical to mature particles except for the
presence of precursor forms of several structural proteins
(Grubisha and Traktman, 2003; Williams et al., 1999).
Thus, the best evidence available suggests that, with the
exception of the addition of the A27L fusion protein to the
particle surface and the presence of precursor forms of
several virion structural proteins, both IV and IVN appear
to contain the full complement of proteins contained in
mature IMV. These findings reinforce the idea that
morphogenesis from IVN to IMV consists largely of an
internal restructuring of preexisting proteins and DNA,
accompanied by proteolytic processing of several virion
structural proteins.Several independent studies have localized the mature 4b
protein to the core wall in mature virions. The 4b protein
comprises 11% of the mass of IMV (Sarov and Joklik,
1972). Immunogold labeling with anti-4b antibody labels
the interior of IV, IVN, and IMV; however, the resolution of
the labeling of IMV is not sufficient to unambiguously
assign the 4b protein to a specific IMV substructure
(Vanslyke and Hruby, 1994). Controlled degradation of
IMV coupled with electrophoretic analysis of the subfrac-
tions obtained localizes the 4b protein either to the inner or
outer surface of the core wall (Ichihashi et al., 1984; Sarov
and Joklik, 1972). Anti-4b antibody reacts strongly with the
surface of isolated cores (Wilton et al., 1995). Interestingly,
one study suggests that the 4b protein may have DNA
binding activity (Ichihashi et al., 1984).
In light of the published studies described above, we
interpret our results to mean that in the two A3L mutants
described here, the mutations in the 4b protein interfere with
the proper structural rearrangements required for the
morphogenetic conversion of IVN to IMV. Importantly, in
mutant infections, a structure forms that resembles a core
bounded by a wall, but the core, and for that matter the
entire particle, is misshapen. Thus, proper formation of the
core wall, determined at least in part by proper function of
the 4b core wall protein, may be critical in determining the
overall shape and organization of the mature IMV particle.
Interestingly, null mutation of the I7L protease results in
formation of aberrant particles that bear striking similarity to
the particles observed here (Ansarah-Sobrinho and Moss,
2004). Clearly, suppression of the I7L protease has more
global effects that ts mutation of A3L, since in the former
case proteolysis of several structural proteins is inhibited,
and the I7L protein, which is normally packaged in virions
(Kane and Shuman, 1993), is absent. Nevertheless, the
similarity between the I7L null infections and the A3L ts
mutant infections suggests that inhibition of processing of
the p4b protein may compromise core wall formation.
The A3L mutant particles are defective in transcription.
We cannot completely rule out the idea that the defect in
transcription results from a deficiency in the virions of a
protein that we have not measured in the experiments
described here. For example, virions lacking the I8R RNA
helicase look like mature IMVs using electron microscopy,
they appear to contain the normal complement of virion
proteins as assessed by one-dimensional SDS-gel electro-
phoresis, and the absence of the I8 protein is revealed only
by Western blot with an appropriate antibody (Gross and
Shuman, 1996). These I8-deficient virions are defective in a
virion transcription reaction despite having a normal comple-
ment of RNA polymerase and early transcription factors as
assayed in a soluble extract. Furthermore, mutants deficient
in the vaccinia H1 phosphatase or the L4 core protein also
produce virions that are structurally normal in appearance
and protein composition, but are defective in virion-directed
transcription (Liu et al., 1995; Wilcock and Smith, 1996).
Nevertheless, we favor an interpretation of our results that
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for proper transcription, hence the disorganized particles
formed in A3L mutant infections are defective in tran-
scription. We envision a relationship between structure and
function of the vaccinia virion that mimics in broad concept
the structure–function relationships that have been revealed
in structural studies of the reovirus virion, in which virion
structural proteins serve a dual role as transcription or RNA
modification enzymes, and the arrangement of these proteins
in the virion structure is critical to proper function of the
virion in transcription (Luongo et al., 2002).Materials and methods
Cell and virus culture, plaque assay, one-step growth
BSC40 cells (a continuous line of African green monkey
kidney cells), wild-type vaccinia virus strain WR, Cts8, and
Cts26, the conditions for cell and virus culture, virus
infection, plaque titration, and one-step growth have been
previously described (Condit and Motyczka, 1981; Condit et
al., 1983). The nonpermissive temperature for mutant
infections was maintained between 39.5 and 40 8C; the
nonpermissive temperature is labeled at 40 8C in figures for
convenience.
Virion thermolability
Virion thermolability was assayed as described by Fathi
and Condit (1991). Briefly, virus suspensions containing 104
pfu of virus were incubated at 45 8C for varying periods of
time, and infectious virus remaining was determined by
plaque titration at 31 8C.
Plasmids, cosmids, and viral DNA
pGA3L contains the A3L open reading frame and was
generated as follows. The precise coding region of the
vaccinia WR A3L (p4b) gene was PCR amplified using
primers that add a PstI and an NdeI site at the 5Vend and a
BamHI site at the 3Vend. The fragment was trimmed with
Pst I and BamHI, and cloned in Pst I–BamHI cut
pGEM3Zf() (Promega).
pBD6 (a gift from Dr. M. Merchlinsky, (Center for
Biologics Evaluation and Research, U.S. Food and Drug
Administration) contains a BstEII concatemer junction
fragment inserted into pUC13 (Merchlinsky et al., 1988).
pWR 93–130, pWR 112–149, pWR 120–150, pWR
133–168, and pWR 143–178 are part of a cosmid library of
vaccinia virus DNA that has been described previously
(Thompson and Condit, 1986) and contain different over-
lapping segments that span the entire HindIII A fragment of
vaccinia virus DNA.
Plasmid pSB24, which contains a synthetic early
vaccinia promoter upstream from a 375 nucleotide G-lesscassette (Luo et al., 1991), was obtained from Dr. Stewart
Shuman (Memorial Sloan Kettering Institute). Plasmid
pCFW10, which contains the vaccinia virus 11k late
promoter (gene F17R) upstream from a 375 nucleotide G-
less cassette (Wright and Moss, 1989), was obtained from
Dr. Cynthia Wright (Medical University of South Carolina).
Cts26 genomic DNA was prepared essentially as
described previously (Condit et al., 1983; Esposito et al.,
1981).
Total infected cell DNA to be used for sequencing of the
A3L gene was isolated using Qiagen DNeasy miniprep spin
columns (Qiagen) according to manufacturer’s instructions
for isolation of DNA from cells in culture as previously
described (Latner et al., 2000).
DNA sequence analysis
DNA sequence of the A3L gene from wt and mutant
viruses was obtained by direct sequencing of PCR products
amplified from total infected cell DNA, prepared as described
above. The entire A3L open reading frame was PCR
amplified using two primers that hybridize outside of the
open reading frame and yield a 2124-bp product. Sequence
was obtained using the amplification primers plus an addi-
tional primer that hybridizes within the coding sequence.
Wild-type A3L gene was sequenced directly from the pGA3L
plasmid using pGem universal sequencing primers and the
same additional A3L coding sequence primer mentioned
above. Sequencing was performed by the University of
Florida ICBR DNA Sequencing Core Laboratory.
Marker rescue
One-step marker rescue was carried out as previously
described (Thompson and Condit, 1986). Briefly, 60-mm
dishes of BSC40 cells were infected with each ts virus at an
appropriate moi determined empirically by terminal dilu-
tion, and 4 h later transfected with 10 Ag of plasmid or
cosmid DNA cloned from wt virus using Lipofectin reagent
(Life Technologies). Infected, transfected cells were incu-
bated at the nonpermissive temperature (40 8C) for 4 days.
The dishes were then stained with crystal violet and scored
for the presence of wild-type plaques.
Genomic DNA-enhanced, two-step marker rescue was
performed as previously described (Fathi et al., 1986).
Briefly, confluent 60-mm dishes of BSC40 cells were
infected at an moi of 0.1 with Cts26 mutant virus. Infected
cells were then overlaid with medium lacking serum and
transfected with 10 Ag of plasmid or cosmid DNA cloned
from wt virus or 10 Ag of Cts26 genomic DNA using
Lipofectin reagent (Life Technologies). Cells were incubated
at 31 8C for an additional 3 h, and then shifted to 40 8C.
Infected, transfected cells were incubated overnight and on
the following day the medium on all of the dishes was
replaced with fresh medium containing serum. Seven days
postinfection, the virus was released from the cells by two
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determined by plaque titration under permissive and non-
permissive conditions.
Protein pulse labeling
Pulse labeling of proteins in infected cells with 35S-labeled
methionine, sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE), and autoradiography were
done as previously described (Condit and Motyczka, 1981).
For pulse-chase experiments, pulse-labeled cells were
washed and incubated in serum-containing medium for
various times, then harvested and analyzed as described
above.
Telomere resolution
The telomere resolution assay was carried out as
described previously (Sekiguchi and Shuman, 1997).
Briefly, monolayers of BSC40 cells in 60-mm dishes were
infected with wt or ts mutant virus at a moi of 10 and
incubated at either 31 or 40 8C. Cells were harvested at 6,
12, and 24 h postinfection. DNA was extracted and cleaved
with BstEII, and Southern blots were prepared and probed
with 32P-labeled pBD6 exactly as described (Sekiguchi and
Shuman, 1997).
Purification and analysis of virus particles
Confluent monolayers of BSC40 cells on 150-mm dishes
were infected with either wt or Cts8 viruses at an moi of 10
at 40 8C. Cells were harvested 24 h after infection, and the
cell-associated virus was purified by pelleting through a
36% sucrose cushion followed by banding on a 24–40%
sucrose gradient as previously described (Ausubel et al.,
1994). As an additional control, virus was also purified from
cells infected at moi = 0.1 and incubated at 37 8C until CPE
was complete. For analysis of viral DNA, 2 Al of each
fraction of the sucrose gradient was diluted in 50 Al of H2O
and applied to a nylon membrane in a slot blot apparatus
(Schleicher and Schuell). The membrane was processed and
hybridized with 32P-labeled vaccinia-specific oligonucleo-
tides as previously described (Lackner et al., 2003). Virion
core and envelope extracts were prepared and analyzed as
described by Gross and Shuman (1996). Briefly, 0.1 A260 of
wt or mutant particles was treated with 50 mM DTT and
0.5% NP40 in 50 mM Tris–HCl pH 8.0, and core and
membrane fractions were separated by centrifugation and
analyzed by SDS-PAGE and silver staining.
Analysis of vaccinia virus DNA by pulsed field
electrophoresis
Vaccinia virus DNA was prepared by in situ digestion
of wt and mutant virions (400 ng DNA) embedded in
agarose plugs and separated by pulsed-field electrophoresis(Bio-Rad CHEF-II-DR system). Embedding of the virions
was done in 1% Seaplaque GTG agarose plugs (prepared
in 0.12 M EDTA pH 8.0) and DNA was released by
incubation in digestion buffer (1% sarkosyl, 10 mM Tris–
HCl pH 8.0, 0.2 M EDTA pH 8.0, 0.5 mg/ml proteinase
K) at 50 8C for 16 h. The agarose plugs were then rinsed
with cold 0.5 TBE and placed in gel sample wells.
Samples were separated in 1% Seakem LE agarose gel in
0.5  TBE buffer and the CHEF-II-DR gel parameters for
DNA separation were 180 V, a pulse ratio of 50-s initial
and 90-s final pulse times, and a run time of 20 h at 4 8C.
Viral DNA bands were visualized by ethidium bromide
staining.
Western blot analysis
Purified virus samples (10 Ag per lane) were electro-
phoresed on 10% SDS-PAGE and transferred to nitro-
cellulose membranes as described (Latner et al., 2000).
The membranes were blocked twice with a solution of
PBS, 0.05% Tween 20 (PBS-T), and 5% nonfat dry milk
(PBS-T/NFDM) for 30 min and then incubated with an
appropriate concentration of primary antibody in PBS-T/
NFDM for 1 h. The membranes were rinsed and washed
three times in PBS-T, and incubated with the appropriate
secondary antibody in PBS-T/NFDM for 1 h. The
membranes were rinsed and washed again in PBS-T, and
developed using an enhanced chemiluminescence detection
kit (Amersham) as directed to visualize the signals. The
dilution and source of antibodies follows: anti-H4 (1:5000)
rabbit serum was supplied by Dr. Bernard Moss (NIAID).
Anti-J6 and anti-A29 (1:1000) rabbit serum was supplied
by Dr. Stewart Shuman (Memorial Sloan Kettering
Institute). Anti-A10 (1:1000), anti-L4 (1:1000), and anti-
A3 (1:1000) rabbit serum was supplied by Dr. Dennis
Hruby (Oregon State University). Anti-H5 (1:1000), anti-
H1 (1:1000), anti-F17 (1:1000), and anti-F10 (1:1000)
rabbit serum was supplied by Dr. Paula Traktman (Medical
College of Wisconsin). Anti-J3 (1:5000), anti-D11
(1:1000), anti-D1 (1:1000 ), anti-E1 (1:500), and anti-D8
(1:500) rabbit serum was supplied by Dr. Edward Niles
(SUNY Buffalo). Mouse monoclonal anti-A18 antibody
(1:10000) has been previously described.
Electron microscopy
Confluent monolayers of BSC40 cells on 60-mm dishes
were infected with either wt or ts viruses at an moi of 10 at
either 31 or 40 8C. At 24 h postinfection, the cells were
washed with 4 ml of 0.1 M sodium cacodylate buffer pH 7.2,
then 2 ml of 2% glutaraldehyde in 0.1 M sodium cacodylate
buffer was added to each dish, and dishes were incubated at
room temperature for 1 h with occasional rocking. Cells
were scraped from the dishes, pelleted at 700  g for 5 min,
resuspended in 0.1 M sodium cacodylate buffer, then stored
at 4 8C before further processing. The cells were collected
S.E.M. Kato et al. / Virology 330 (2004) 127–146144by centrifugation, postfixed in 1% osmium tetroxide,
dehydrated in grade series of ethanol solutions and 100%
acetone, and embedded in Embed-812 resin mix. En bloc
staining was done with uranyl acetate solution in 75%
ethanol. Following thin sectioning, the samples were
poststained in uranyl acetate and Reynolds lead acetate.
After mounting, the samples were viewed on a Hitachi
H7000 transmission electron microscope. Embedding, thin
sectioning, staining, and microscopy were done with
assistance of the University of Florida ICBR Electron
Microscopy Core Laboratory.
For electron microscopy of purified particles, material
banded on 24–40% sucrose gradients was used. Aliquots
(0.4 ml) of fractions 12–16 of purified viral particles (Fig. 8)
were pooled and resuspended in Tris–HCl 10 mM pH 8.0.
The suspension was centrifuged at 16000 rpm for 1 h,
pelleted particles were resuspended in 200 Al of 0.1 M
cacodylate buffer, incubated with equal volume of 4%
glutaraldehyde in 0.1 M cacodylate buffer, and collected by
centrifugation in a microcentrifuge. Samples were embed-
ded in Embed-812 and processed for electron microscopy as
previously described above.
Transcription by permeabilized virions
Permeabilized virion transcription reactions were done as
described by Gross and Shuman (1996). To measure total
incorporation into RNA, reactions containing 60 mM Tris–
HCl pH 8.5, 0.05% nonidet P40 (NP40), 10 mM dithio-
threitol (DTT), 10 mM MgCl2, 5 mM ATP, 1 mM UTP, 1
mM GTP, 0.2 mM a 32P-CTP (100 ACi/Amol), and 1 A260/
ml of virus were incubated at 37 8C, and 50-Al aliquots were
precipitated directly with 5% TCA. To measure virion core
associated versus released RNA, identical reactions were
used and 50-Al aliquots were diluted into 200-Al stop
solution (50 mM Tris–HCl pH 8.0, 10 mM DTT, 10 mM
EDTA, 0.05% NP40), then centrifuged for 3 min in a
microfuge. Supernatants (released RNA) were removed and
precipitated with 5% TCA. Pellets (core associated RNA)
were resuspended in 0.2 ml of a buffer containing 50 mM
Tris–HCl, pH 8.0, 0.1% SDS, and precipitated with 5%
TCA. TCA precipitable radioactivity was determined by
liquid scintillation counting.
Electrophoretic analysis of RNA synthesized by
permeabilized virions
Fifty-microliter aliquots of a transcription reaction
(described above) were purified by proteinase K treatment,
and phenol-chloroform extraction and concentrated by
isopropanol precipitation as described by Lackner and Condit
(2000). RNA pellets were resuspended in formamide/form-
aldehyde containing MOPS buffer, heat denatured, and
electrophoresed on a 1.2% denaturing formaldehyde gel as
described by Latner et al. (2002). The gel was dried and
autoradiographed.Preparation and assay of soluble virion transcription
extracts
Soluble transcription extracts were prepared and assayed
essentially as described by Gross and Shuman (1996). All
extraction and chromatography steps were carried out at 4 8C.
2.5 A260 units of virus was concentrated by centrifugation in a
microfuge for 5 min, resuspended in 150 Al of buffer E (300
mM Tris–HCl, pH 8.0, 250 mM NaCl, 0.1 mM EDTA, 50
mMDTT, and 0.05%NP40), and incubated on ice for 10min.
Eight microliters of 2% deoxycholate was added, and the
mixture was incubated on ice for an additional 30 min with
occasional mixing by trituration with a micropipette. The
mixture was centrifuged in a microfuge for 5 min and the
supernatant applied to a 150-Al column of DEAE cellulose
(Whatman DE-52) poured in a 1-ml tuberculin syringe and
equilibrated with buffer E. The columnwas eluted with buffer
E collecting 9  3 drop fractions, each with an approximate
volume of 75 Al. Nineteen microliters of glycerol solution
(250 mM Tris–HCl, pH 8.0, 10 mMDTT, 5 mM EDTA, 50%
glycerol) was added to each fraction, and the fractions were
stored at 80 8C.
Fractions from the DEAE column were assayed for
nonspecific RNA polymerase activity as follows: reactions
(100 Al) containing 60 mM Tris–HCl, pH 8.0, 10 mM DTT,
3 mM MnCl2, 1 mM ATP, 1 mM GTP, 1 mM UTP, 0.1 mM
a 32P-CTP (25 ACi/Amol), 1 Ag ssDNA (from bacteriophage
M13), and 8 Al enzyme were incubated at 37 8C for 30 min.
Incorporation of 32P-CTP into RNA was measured by
precipitation in 5% TCA. Peak fractions were pooled and
stored in aliquots at 80 8C.
Promoter-specific transcription by virion extracts was
assayed as follows: reactions (60 Al) containing 40 mM
Tris–HCl, pH 8.0, 4 mM DTT, 12 mM MgCl2, 1 mM ATP,
1 mM UTP, 10 AM a 32P-CTP (800 ACi/Amol), 0.1 mM 3V-
O-me-GTP, 0.5 Ag DNA, and 1–8 Al enzyme were
incubated at 30 8C for 30 min. Reactions contained
equivalent amounts of RNA polymerase activity, deter-
mined by performing a time course of nonspecific tran-
scription with varying amounts of virion extract. RNA was
purified from transcription reactions by proteinase K treat-
ment and phenol/chloroform extraction as described above,
and analyzed by electrophoresis on 4% denaturing poly-
acrylamide/urea gels.Acknowledgments
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